Back to companies

Prestige BioPharma Limited

950210KRKRX

프레스티지바이오파마

Revenue
—
FY2024
Operating income
-₩47.1mn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)